Toxicokinetics in preclinical evaluation-Reference-Cited by-同舟云学术

Toxicokinetics in preclinical evaluation

Published:2003-01 Issue:3 Volume:8 Page:127-133
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Baldrick Paul

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference32 articles.

1. CPMP/ICH/384/95: Operational June 1995. Toxicokinetics: a guidance for assessing systemic exposure in toxicology studies. Also known as ICH Topic S3A (see http://www.emea.eu.int)

2. Toxicokinetics;Medinsky,2001

3. CPMP/ICH/286/95, modification: operational November 2000. Non-clinical safety studies for the conduct of human clinical trails for pharmaceuticals. Also known as ICH Topic M3 (see http://www.emea.eu.int)

4. CPMP/SWP/1042 Corr: operational October 2000. Note for guidance on repeated dose toxicity (see http://www.emea.eu.int)

5. Toxicokinetics in preclinical safety assessment – views from the Swedish Medical Products Agency;Sjoberg;Drug Inf. J.,1994

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of toxicokinetic data in preclinical safety assessment;Public Health and Toxicology Issues Drug Research, Volume 2;2024

2. Design of toxicokinetic studies;Public Health and Toxicology Issues Drug Research, Volume 2;2024

3. Pharmacokinetics and Toxicokinetics;Handbook of Pharmacokinetics and Toxicokinetics;2023-07-03

4. Toxicokinetics of recombinant human fibroblast growth factor 21 for injection in cynomolgus monkey for 3 months;Frontiers in Pharmacology;2023-05-23

5. Application of a developed triple-classification machine learning model for carcinogenic prediction of hazardous organic chemicals to the US, EU, and WHO based on Chinese database;Ecotoxicology and Environmental Safety;2023-04